Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Considers Bulk Buys Of Costly MNC Devices, Drugs

This article was originally published in PharmAsia News

Executive Summary

Indian authorities are considering buying certain medical devices and drugs in volume to ensure they are more affordable to Indians who need them. Under the plan, multinational companies would be barred from having direct access to patients if they have a monopoly over expensive products. Government officials believe the companies also would benefit because they would have a massive contract for their products without the high cost of promoting them. Some drug makers already sell pharmaceuticals in India at prices lower than those they charge in developed countries. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069061

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel